News releases

	Danish

	News release archive

Presentations

Finance

2010 News releases:

	NeuroSearch announces the issuance of an EHDN statement supporting the statistical conclusions on the primary endpoint of the MermaiHD study 04 September 2010 - Announcement

	NeuroSearch announces publication of the unique pharmacological profile of Huntexil^® (pridopidine) in the European Journal of Pharmacology 02 September 2010 - Press release

	NeuroSearch A/S – Interim report for H1 2010 25 August 2010 - Announcement

	NeuroSearch names Patrik Dahlen as the company's new CEO 24 August 2010 - Announcement

	NeuroSearch – Release date for the H1 2010 interim report 18 August 2010 - Press release

	NeuroSearch announces that 27%-owned NsGene A/S signs new agreement with Biogen Idec on therapeutic protein, Neublastin 10 August 2010 - Announcement

	New article published in The Lancet reveals massive underestimation of the prevalence of Huntington’s disease in the UK 30 June 2010 - Press release

	NeuroSearch announces that CEO Flemming Pedersen resigns to take up a new position 31 May 2010 - Announcement

	NeuroSearch associate Atonomics A/S (19% owned) completes the development of Atolyzer™, a novel and unique diagnostic instrument 19 May 2010 - Press release

	Report on Extraordinary General Meeting held in NeuroSearch A/S 03 May 2010 - Announcement

	Report on Ordinary General Meeting held in NeuroSearch A/S 28 April 2010 - Announcement

	NeuroSearch A/S – Interim report for Q1 2010 28 April 2010 - Announcement

	NeuroSearch A/S announces the results of additional assessment and analysis of data from the Phase III MermaiHD study with Huntexil^® in Huntington's disease 28 April 2010 - Announcement

	NeuroSearch – Release date for the Q1 2010 interim report 22 April 2010 - Press release

	Notice convening Extraordinary General Meeting in NeuroSearch A/S 06 April 2010 - Announcement

	Notice convening Annual General Meeting in NeuroSearch A/S 06 April 2010 - Announcement

	NeuroSearch A/S – Share capital and voting rights 31 March 2010 - Announcement

	NeuroSearch issues new shares in connection with the exercise of warrants 22 March 2010 - Announcement

	NeuroSearch issues new shares in connection with the exercise of warrants 16 March 2010 - Announcement

	List of NeuroSearch announcements in 2009 and in January - March 2010 10 March 2010 - Announcement

	NeuroSearch A/S – Financial statements 2009 10 March 2010 - Announcement

	NeuroSearch announces new findings from the MermaiHD Phase III study supporting potential disease modifying properties of Huntexil^® 08 March 2010 - Announcement

	Release date for NeuroSearch’s 2009 announcement and related telephone conference 04 March 2010 - Press release

	NeuroSearch presents additional data from the MermaiHD study with Huntexil^® at the 5th Annual CHDI Conference on Huntington's disease 11 February 2010 - Press release

	NeuroSearch announces positive top-line results from Phase III Huntexil^® study in Huntington's disease (the MermaiHD study) 03 February 2010 - Announcement

Presentations

	26 August 2010 H1 2010 Interim - Company presentation
	25 August 2010 Q2 Report 2010 - Teleconference

Download annual reports

	15 March 2010 Årsrapport 2009